Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $735.9400 (-0.1%) ($728.4000 - $735.9400) on Mon. Oct. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 64 | Latest Price | $735.9400(-0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(35%) SPLV(33%) IWD(31%) SDY(30%) | Factors Impacting REGN price | REGN will decline at least -1.5% in a week (0% probabilities). TBT(-12%) UUP(-3%) VIXM(-2%) VCSH(-2%) VXX(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $738.23(-0.31%) | 10 Day Moving Average | $736.22(-0.04%) | 20 Day Moving Average | $718.46(2.43%) | To recent high | -2.3% | To recent low | 28.2% | Market Cap | $78.031b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |